Form D Explorer

Source evidence

Grace Therapeutics, Inc. · 0001123292-26-001084

D filed Aug. 11, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
PRINCETON
street1
103 CARNEGIE CENTER
street2
SUITE 300
zipCode
08540
entityName
Grace Therapeutics, Inc.
entityType
Corporation
stateOrCountry
New Jersey
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold9999998number9999998/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions560000number560000/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount9999998number9999998/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment1number1/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count9number9/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 6781cedb0d15b0f82320c3f227eff6cf96f9a5b3f2d16d48ac4521a4d8ea4cf3. This proves extraction identity, not the accuracy of the filer's claims.